Cannabis abuse and vulnerability to psychosis: targeting preventive services

Anna Kolliakou; Paolo Fusar-Poli; Zerrin Atakan

doi:10.2174/138161212799316208

Cannabis abuse and vulnerability to psychosis: targeting preventive services

Anna Kolliakou, Paolo Fusar-Poli, Zerrin Atakan^*

^*Corresponding author for this work

King's College London

Research output: Contribution to journal › Literature review › peer-review

12 Citations (Scopus)

Abstract

Cannabis is the most widely used illicit substance in the world and due to the high levels of use observed among young people with psychosis, most research has focused on the causal relationship between cannabis use and mental health problems. Despite a large interest in developing intervention models to target this group, there are as yet no established and effective methods of prevention and intervention focusing on cannabis use. In this paper we present the available evidence for the effectiveness of substance use treatments in patients with co-morbid severe mental illness, as well as exploring the prevention and early intervention initiatives for substance use in the general population.

Original language	English
Pages (from-to)	542-549
Number of pages	8
Journal	Current Pharmaceutical Design
Volume	18
Issue number	4
DOIs	https://doi.org/10.2174/138161212799316208
Publication status	Published - Feb 2012

Keywords

Cannabis
marijuana
psychosis
prevention
intervention
SUBSTANCE USE DISORDERS
RANDOMIZED CONTROLLED-TRIAL
DRUG-USE DISORDERS
FOLLOW-UP
1ST-EPISODE SCHIZOPHRENIA
COMORBID SCHIZOPHRENIA
SWEDISH CONSCRIPTS
MARIJUANA USE
YOUNG-PEOPLE
HIGH-RISK

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2174/138161212799316208

Cite this

@article{1b511b819a6048a392eebbdcf7567ef3,

title = "Cannabis abuse and vulnerability to psychosis: targeting preventive services",

abstract = "Cannabis is the most widely used illicit substance in the world and due to the high levels of use observed among young people with psychosis, most research has focused on the causal relationship between cannabis use and mental health problems. Despite a large interest in developing intervention models to target this group, there are as yet no established and effective methods of prevention and intervention focusing on cannabis use. In this paper we present the available evidence for the effectiveness of substance use treatments in patients with co-morbid severe mental illness, as well as exploring the prevention and early intervention initiatives for substance use in the general population.",

keywords = "Cannabis, marijuana, psychosis, prevention, intervention, SUBSTANCE USE DISORDERS, RANDOMIZED CONTROLLED-TRIAL, DRUG-USE DISORDERS, FOLLOW-UP, 1ST-EPISODE SCHIZOPHRENIA, COMORBID SCHIZOPHRENIA, SWEDISH CONSCRIPTS, MARIJUANA USE, YOUNG-PEOPLE, HIGH-RISK",

author = "Anna Kolliakou and Paolo Fusar-Poli and Zerrin Atakan",

year = "2012",

month = feb,

doi = "10.2174/138161212799316208",

language = "English",

volume = "18",

pages = "542--549",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "4",

}

TY - JOUR

T1 - Cannabis abuse and vulnerability to psychosis

T2 - targeting preventive services

AU - Kolliakou, Anna

AU - Fusar-Poli, Paolo

AU - Atakan, Zerrin

PY - 2012/2

Y1 - 2012/2

N2 - Cannabis is the most widely used illicit substance in the world and due to the high levels of use observed among young people with psychosis, most research has focused on the causal relationship between cannabis use and mental health problems. Despite a large interest in developing intervention models to target this group, there are as yet no established and effective methods of prevention and intervention focusing on cannabis use. In this paper we present the available evidence for the effectiveness of substance use treatments in patients with co-morbid severe mental illness, as well as exploring the prevention and early intervention initiatives for substance use in the general population.

AB - Cannabis is the most widely used illicit substance in the world and due to the high levels of use observed among young people with psychosis, most research has focused on the causal relationship between cannabis use and mental health problems. Despite a large interest in developing intervention models to target this group, there are as yet no established and effective methods of prevention and intervention focusing on cannabis use. In this paper we present the available evidence for the effectiveness of substance use treatments in patients with co-morbid severe mental illness, as well as exploring the prevention and early intervention initiatives for substance use in the general population.

KW - Cannabis

KW - marijuana

KW - psychosis

KW - prevention

KW - intervention

KW - SUBSTANCE USE DISORDERS

KW - RANDOMIZED CONTROLLED-TRIAL

KW - DRUG-USE DISORDERS

KW - FOLLOW-UP

KW - 1ST-EPISODE SCHIZOPHRENIA

KW - COMORBID SCHIZOPHRENIA

KW - SWEDISH CONSCRIPTS

KW - MARIJUANA USE

KW - YOUNG-PEOPLE

KW - HIGH-RISK

U2 - 10.2174/138161212799316208

DO - 10.2174/138161212799316208

M3 - Literature review

C2 - 22239586

SN - 1381-6128

VL - 18

SP - 542

EP - 549

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

IS - 4

ER -

Cannabis abuse and vulnerability to psychosis: targeting preventive services

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this